The coronary artery bypass grafts market is expected to reach a valuation of US$ 17,612.1 million in 2023, indicating a consistent upward trend. In the upcoming ten years, the industry is expected to grow to a staggering US$ 22,765.9 million by 2033. Even though the sector’s Compound Annual Growth Rate (CAGR) is currently 2.6%, there are still opportunities for growth and development in this area.
Coronary artery bypass grafting (CABG) procedures remain a vital intervention for addressing coronary artery disease, ensuring blood flow to the heart muscle. The growing prevalence of cardiovascular diseases, coupled with the global aging population, continues to drive the demand for CABG procedures.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1070
Medical advancements, including minimally invasive techniques and innovative materials for grafting, are expected to play a pivotal role in reviving and potentially accelerating market growth. Further research, development, and innovation in this field are essential for improving patient outcomes and reducing the prevalence of cardiovascular conditions worldwide.
Key Takeways:
- Steady Growth: The Coronary Artery Bypass Graft (CABG) market is experiencing a consistent expansion, primarily due to the ongoing demand for coronary artery disease interventions.
- Growing Cardiovascular Disease Prevalence: The market is driven by the increasing prevalence of cardiovascular diseases, which necessitate CABG procedures to ensure proper blood flow to the heart muscle.
- Global Aging Population: As the world’s population ages, the demand for CABG procedures is expected to continue rising, especially among elderly individuals who are more susceptible to heart-related conditions.
- Medical Advancements: Ongoing advancements in minimally invasive surgical techniques and innovative grafting materials hold promise for enhancing patient outcomes and potentially accelerating market growth.
- Research and Development: Continued research and innovation in the field are crucial for improving cardiac care and reducing the global burden of cardiovascular diseases.
- Potential for Further Innovation: The CABG market offers opportunities for further innovation and development, driven by a commitment to enhancing treatment options and patient outcomes.
Key Companies:
- Medtronic
- TERUMO CORPORATION
- Guidant Group
- MAQUET Holding B.V. & Co. K.G.
- Vitalitec International, Inc.
- Novadaq Technologies Inc.
- KARL STORZ GmbH & Co. K.G.
- Edwards Lifesciences
- Genesee Biomedical Inc.
- Sorin Group
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-1070
Key Segments
By Technology:
- Off-pump CABG
- On-pump CABG
- Others
By Procedure:
- Single CABG surgery
- Double CABG surgery
- Triple CABG surgery
- Quadruple CABG surgery
- Others
By End User:
- Hospitals
- Cardiology Clinics
- Research Institutes
- Others
By Region:
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube